908 Devices raises 2026 revenue outlook after 23% second-quarter growth

MarketBeat··US·Read original
2▲1 ▼0Impact / 5
Summary · why it matters

908 Devices reported second-quarter revenue rose 23% to $16.1 million and raised its full-year 2026 revenue guidance to $68 million to $70 million. The company shipped 198 devices, expanding its installed base to 4,101, and saw gross margin improve to 52% while adjusted EBITDA loss narrowed by more than half to $1.9 million. It ended the quarter with $101.5 million in cash and marketable securities and no debt. A recently won $6 million ProtectIR order is expected to contribute in the second half, while potential upside from the U.S. military's AVCAD program remains excluded from guidance due to uncertain timing.

Impact on assets 1

Biotech & Genomic Medicine▲ · 1 stocks
908 Devices Inc
MASS
▲ PositiveCapitalrelevance

Raises 2026 revenue guidance and reports strong Q2 growth, improved margins, and narrowed losses.